THE ROLE OF SULFATE CONJUGATION IN THE METABOLISM AND DISPOSITION OF ORAL AND INTRAVENOUS PARACETAMOL IN MAN
THE ROLE OF SULFATE CONJUGATION IN THE METABOLISM AND DISPOSITION OF ORAL AND INTRAVENOUS PARACETAMOL IN MAN
复制标题
DOI:
10.1111/j.1365-2125.1984.tb02495.x
复制
发表时间:
1984-01-01
影响因子:
3.4
通讯作者:
PRESCOTT, LF
中科院分区:
文献类型:
--
作者:
CLEMENTS, JA;CRITCHLEY, JAJH;PRESCOTT, LF
The effects of paracetamol dose (5 and 20 mg/kg) and route of administration (i.v. and oral) on the urinary excretion of paracetamol and its glucoronide, sulfate, cysteine and mercapturic acid conjugates were studied in 5 healthy subjects. The fractional urinary excretion of unchanged paracetamol and its conjugates was independent of the route of administration at both dose levels, suggesting that the gastrointestinal tract is not an important site for paracetamol metabolism. The percentage of the dose excreted as the sulfate conjugate was significantly higher after 5 than after 20 mg/kg (37.7% and 33.3%, respectively) and this is consistent with saturation of sulfate conjugation. No significant effect of paracetamol dose upon the area under the plasma concentration-time curve (AUC), corrected for dose, was found for the sulfate or glucuronide conjugates. The total plasma clearance of paracetamol and the renal clearance of the sulfate conjugate were significantly higher after the 5 than the 20 mg/kg dose (331 .+-. 42 ml/min and 295 .+-. 48 ml/min; 273 .+-. 74 ml/min and 205 .+-. 46 ml/min, respectively). The oral systemic availability of paracetamol was 80% and independent of dose.